1. Agami R, Blandino G, Oren M, Shaul Y. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature. 1999; 399:809–813. PMID:
10391250.
2. Augustin M, et al. Cloning and chromosomal mapping of the human p53-related KET gene to chromosome 3q27 and its murine homolog Ket to mouse chromosome 16. Mamm Genome. 1998; 9:899–902. PMID:
9799841.
Article
3. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X, Crook T. P53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell. 2003; 3:387–402. PMID:
12726864.
Article
4. Brodsky MH, et al. Drosophila p53 binds a damage response element at the reaper locus. Cell. 2000; 101:103–113. PMID:
10778860.
Article
5. Di Como CJ, Gaiddon C, Prives C. P73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol Cell Biol. 1999; 19:1438–1449. PMID:
9891077.
Article
6. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 1992; 356:215–221. PMID:
1552940.
Article
7. Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T. P63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 2002; 416:560–564. PMID:
11932750.
Article
8. Geddert H, Kiel S, Heep HJ, Gabbert HE, Sarbia M. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis. Hum Pathol. 2003; 34:850–856. PMID:
14562279.
9. Gerhard J, Kirschner M. Cells, Embryos, and Evolution. 1997. Malden, MA: Blackwell Science.
10. Gong JG, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 1999; 399:806–809. PMID:
10391249.
Article
11. Heselmeyer K, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc. Natl Acad Sci USA. 1996; 93:479–484.
12. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, Sidransky D. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA. 2000; 97:5462–5467. PMID:
10805802.
Article
13. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, Kaelin WG Jr. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature. 2000; 407:645–648. PMID:
11034215.
Article
14. Irwin MS, Kondo K, Marin MC, Cheng LS, Hahn WC, Kaelin WG Jr. Chemosensitivity linked to p73 function. Cancer Cell. 2003; 3:403–410. PMID:
12726865.
Article
15. Jost CA, Marin MC, Kaelin WG Jr. P73 is a simian p53-related protein that can induce apoptosis. Nature. 1997; 389:191–194. PMID:
9296498.
16. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F, Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997; 90:809–819. PMID:
9288759.
Article
17. Levine A. P53, the cellular gatekeeper for growth and division. Cell. 1997; 88:323–331. PMID:
9039259.
Article
18. Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature. 2000; 407:642–645. PMID:
11034214.
Article
19. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin WG Jr. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet. 2000; 25:47–54. PMID:
10802655.
Article
20. Ollmann M. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell. 2000; 101:91–101. PMID:
10778859.
Article
21. Osada M, et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med. 1998; 4:839–843. PMID:
9662378.
Article
22. Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L, Porcellini A, Screpanti I, Balsano C, Alesse E, Gulino A, Levrero M. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol. 2003; 5:552–558. PMID:
12766778.
Article
23. Phillips AC, Vousden KH. E2F-1 induced apoptosis. Apoptosis. 2001; 6:173–182. PMID:
11388666.
24. Pozniak CD, Radinovic S, Yang A, McKeon F, Kaplan DR, Miller FD. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science. 2000; 289:304–306. PMID:
10894779.
Article
25. Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J, du Manoir S. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res. 2001; 61:4122–4129. PMID:
11358835.
26. Senoo M, Seki N, Ohira M, Sugano S, Watanabe M, Inuzuka S, Okamoto T, Tachibana M, Tanaka T, Shinkai Y, Kato H. A second p53-related protein, p73L, with high homology to p73. Biochem Biophys Res Commun. 1998; 30:603–607. PMID:
9703973.
Article
27. Stiewe T, Putzer BM. Role of the p53-homologue p73 in E2F1-induced apoptosis. Nat Genet. 2000; 26:464–469. PMID:
11101847.
Article
28. Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D. A new human p53 homologue. Nat Med. 1998; 4:747–748. PMID:
9662346.
Article
29. White E, Prives C. DNA damage enables p73. Nature. 1999; 399:734–735. PMID:
10391235.
Article
30. Versteeg R, et al. 1p36: every subband a suppressor? Eur J Cancer. 1995; 31:538–541. PMID:
7576962.
Article
31. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F. P63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998; 2:305–316. PMID:
9774969.
Article
32. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999; 398:714–718. PMID:
10227294.
Article
33. Yang A, Kaghad M, Caput D, McKeon F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 2002; 18:90–95. PMID:
11818141.
Article
34. Yang A, McKeon F. P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol. 2000; 1:199–207. PMID:
11252895.
Article
35. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D. P73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature. 2000; 404:99–103. PMID:
10716451.
Article
36. Yuan ZM, et al. P73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature. 1999; 399:814–817. PMID:
10391251.
Article